IBRX ImmunityBio reports narrower than projected Q4 2025 per share loss while its stock holds steady for the trading session Is Middleby MIDD stock a good option for investors Middleby posts 43 EPS beat topping consensus analyst forecasts BTQ Tech Corp Q4 2025 EPS misses analyst estimates by a wide margin shares fall 128 percent today CFGE CitizensPfdE has not published detailed quarterly earnings or performance metrics for the recent reporting period Truist Financial Corp TFC Analysts Affirm Salesforce CRM Buy Rating Citing Fixable Agentforce Pricing Headwinds Goldman Sachs GS Yen Breaches 160 Per Dollar Threshold Intervention Risk and CrossMarket Implications